Clinical trial
Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes…
NCT00331487 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00331487 |
|---|---|
| Title | Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia |
| Official title | Pioglitazone Versus Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia |
| Lead sponsor | Takeda, Industry |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Pioglitazone, Rosiglitazone |
| Enrollment | 719 |
| Start date | Sep 1, 2000 |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | May 31, 2006 |
| Last update posted | Feb 28, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: